Table 1.
Case No. | Age | Corpus cancer |
Ovarian cancer |
Chemotherapy (1st line) | Operation | ||
---|---|---|---|---|---|---|---|
Histology | FIGO stage | Histology | FIGO stage | ||||
1a | 51 | EA, G1 | IB | EA, G1b | IA | TC | TAH + BSO |
2 | 51 | EA, G1 | IA | EA, G1 | IC(a) | TC | TAH + BSO |
3 | 53 | EA, G1 | IA | EA,G1 | IA | TC | TAH + BSO + PLN + PAN + POM |
4 | 44 | EA, G1 | IA | EA,G1b | IA | – | TAH + BSO |
5 | 45 | EA, G3 | IB | EA,G2 | IIIA | TC | TAH + BSO + POM |
6 | 74 | EA or MA | IIIA | EA or MA | IIC(b) | ddTC | TAH + BSO |
7 | 49 | EA, G1 | IA | MA | IC1 | – | TAH + BSO + POM + APE |
8 | 62 | EA, G1 | IA | mucinous borderline tumor intestinal type | IA | – | TAH + BSO |
9 | 48 | EA, G1 | IA | serous borderline adenofibroma | IC3 | – | TAH + BSO + POM |
EA: Endometrial adenocarcinoma, MA: Mucinous adenocarcinoma, TC: paclitaxel and carboplatin, ddTC: dose dense TC, TAH: Total abdominal hysterectomy, BSO: Bilateral salpingo-oophorectomy, PLN: Pelvic lymphadenectomy, PAN: Para-aortic lymphadenectomy, POM: Partial omentectomy, APE: Appendectomy
present patient.
ovarian endometriosis.